The use of on-a-chip technologies has seen enormous growth across the biomedical sciences in recent years, but how can this approach be harnessed to further understand dementia and develop new therapies?
Michael discusses his work, progress towards diagnosis of chronic traumatic encephalopathy in life and his thoughts on the latest in CTE research.
Dr Deer discusses his career highlights, most memorable patient cases, and looks ahead at future challenges and trends in the field of neuromodulation.
Michael Pender discusses promising interim findings from a Phase 1 study investigating a novel treatment for multiple sclerosis.
Eric Wasserman discusses tells us more about his work, uses for noninvasive brain stimulation, and the potential for neuromodulation in the treatment of neurological disorders.
James Coffman responds to questions from our recent webinar, ‘How chronic stress experienced during early development epigenetically programs adult disease risk’.
Emery Brown discusses how general anesthesia can be used to understand and develop new treatments for neurological conditions, and looks ahead at the future of the field.
Curt Freed discusses his pioneering work on transplanting human fetal dopaminergic cells, and where Parkinson’s disease research and treatment is heading in the next decade.
In this edition of NCTalks, we speak to Robyn Klein as part of our Spotlight on neuroimmunology – Robyn discusses her research, how inflammatory processes contribute to neurologic disease, and whether immunology and inflammation could be the basis of an eventual preventative treatment for neurodegenerative disease.
Lauren Pulling speaks to Bart De Strooper about his role as the Director of the new UK Dementia Research Institute and his vision for this exciting new venture.